Streaming media company Roku will likely have an initial public offering before the end of the year, adding another public company to a crowded field. Rumors are Roku is worth about $1 billion
The Congressional Budget Office (CBO) reports that Trump will not be able to balance the U.S. budget for a decade based on the president’s current plans.
Online fantasy betting sites DraftKings and FanDuel will not merge as expected. Both have faced regulatory problems and rising marketing costs. It was assumed that the two very similarcompanies could save money by eliminatingduplicate costs
Honda Motor Co. Ltd. (NYSE: HMC) recalled 1.2 million Accord models. According to the AP:
Honda is recalling 1.2 million Accord midsize cars in the U.S. because a battery sensor can short out and potentially cause a fire.
The recall covers cars from the 2013 through 2016 model years. Honda says it has four reports of engine compartment fires due to the problem but no injuries. All the fires were in states where salt is used to clear roads in the winter.
stock forum: Ormat Technologies, Inc.(ORA)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows shares of U.S. Geothermal back in positive territory while potential peer mid cap Calpine Corporation (NYSE: CPN) is underperforming and Ormat Technologies, Inc (NYSE: ORA) has been taking off for two years:
stock forum: Akorn, Inc.(AKRX)
Advisors’ Opinion:
- [By Alex McGuire]
As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…
Pharmaceutical Stock Current Share Price April 2017 Gain
Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%
The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.
- [By Wayne Duggan]
Akorn, Inc. (NASDAQ: AKRX) shares are up 18.2 percent on Friday after Bloomberg reported Frensius is considering a buyout bid for Akorn.
The news came just hours after Benzinga alerted its pro subscribers to an unusually large Akorn call purchase on the options market.
- [By Dan Caplinger]
Despite a lack of conviction in the market at large, some stocks posted sharp gains on Friday, and Diana Shipping (NYSE:DSX), Akorn (NASDAQ:AKRX), and Granite Construction (NYSE:GVA) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.
- [By Lisa Levin]
In trading on Friday, healthcare shares fell by 0.62 percent. Meanwhile, top losers in the sector included Akorn, Inc. (NASDAQ: AKRX), down 17 percent, and BioDelivery Sciences International, Inc. (NASDAQ: BDSI), down 14 percent.
- [By Ben Levisohn]
Shares of Endo International (ENDP) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink’s Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models–and find Akorn (AKRX), Perrigo (PRGO), and Teva Pharmaceutical Industries (TEVA). They explain:
- [By Wayne Duggan]
Akorn, Inc. (NASDAQ: AKRX) shares are drifting higher by 0.27 percent (about $0.10 per share) Wednesday after jumping 3.2 percent Tuesday following a report the company was on the verge of a buyout deal.
stock forum: C.H. Robinson Worldwide, Inc.(CHRW)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) were down 4 percent to $71.69. UBS downgraded C.H. Robinson Worldwide from Neutral to Sell.
- [By Gary Jakacky]
Only one company convincingly jumped thru all the hoops: C.H. Robinson Worldwide, Inc. (CHRW).
If only one of the companies in IYT appear to be undervalued, it might give you pause about how brightly the ETF will shine in the very near future.
- [By Chad Tracy]
As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.
Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.
stock forum: Uranium Resources, Inc.(URRE)
Advisors’ Opinion:
- [By Lisa Levin]
Uranium Resources, Inc. (NASDAQ: URRE) was down, falling around 12 percent to $2.37 after the company reported a closing of $9.7 million public offering.
- [By Lisa Levin]
Uranium Resources, Inc. (NASDAQ: URRE) shares dropped 19 percent to $2.55 after the company reported the pricing of $9.7 million public offering.
